Phase I/II trial of Hi-8 PrimeBoost therapeutic vaccine in stage III/IV metastatic melanoma

R. Hawkins; A. Dangoor; P. Lorigan; U. Keilholz; D. Schadendorf; C. Ottensmeier; J. Smyth; K. Hoffmann; M. Cripps

doi:10.1097/00008390-200609001-00059

Phase I/II trial of Hi-8 PrimeBoost therapeutic vaccine in stage III/IV metastatic melanoma

R. Hawkins
, A. Dangoor
, P. Lorigan
, U. Keilholz
, D. Schadendorf
, C. Ottensmeier
, J. Smyth
, K. Hoffmann
, M. Cripps

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	S34
Journal	Melanoma research
Volume	16
Issue number	Supplement 1
DOIs	https://doi.org/10.1097/00008390-200609001-00059
Publication status	Published - Sept 2006

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1097/00008390-200609001-00059

Cite this

@article{914c02a5912e4861af0c585a261f4aec,

title = "Phase I/II trial of Hi-8 PrimeBoost therapeutic vaccine in stage III/IV metastatic melanoma",

author = "R. Hawkins and A. Dangoor and P. Lorigan and U. Keilholz and D. Schadendorf and C. Ottensmeier and J. Smyth and K. Hoffmann and M. Cripps",

year = "2006",

month = sep,

doi = "10.1097/00008390-200609001-00059",

language = "English",

volume = "16",

pages = "S34",

journal = "Melanoma research",

issn = "0960-8931",

publisher = "Lippincott Williams \& Wilkins",

number = "Supplement 1",

}

TY - JOUR

T1 - Phase I/II trial of Hi-8 PrimeBoost therapeutic vaccine in stage III/IV metastatic melanoma

AU - Hawkins, R.

AU - Dangoor, A.

AU - Lorigan, P.

AU - Keilholz, U.

AU - Schadendorf, D.

AU - Ottensmeier, C.

AU - Smyth, J.

AU - Hoffmann, K.

AU - Cripps, M.

PY - 2006/9

Y1 - 2006/9

UR - http://www.mendeley.com/research/phase-iii-trial-hi8-primeboost-therapeutic-vaccine-stage-iiiiv-metastatic-melanoma

U2 - 10.1097/00008390-200609001-00059

DO - 10.1097/00008390-200609001-00059

M3 - Article

SN - 0960-8931

VL - 16

SP - S34

JO - Melanoma research

JF - Melanoma research

IS - Supplement 1

ER -

Phase I/II trial of Hi-8 PrimeBoost therapeutic vaccine in stage III/IV metastatic melanoma

UN SDGs

Access to Document

Other files and links

Cite this